UK cost agency rejects leukaemia drug from J&J and AbbVie
 

UK cost agency rejects leukaemia drug from J&J and AbbVie
LONDON, March 2 (Reuters) - A new leukaemia drug viewed by industry experts as a future blockbuster has been rejected by Britain's healthcare cost-effectiveness agency NICE, which said it could **t be confident the medicine represented an effective use of resources.


http://rc.feedsportal.com/r/24739335...13/rc/1/rc.img

http://rc.feedsportal.com/r/24739335...13/rc/2/rc.img

http://rc.feedsportal.com/r/24739335...13/rc/3/rc.img

http://da.feedsportal.com/r/24739335...a/sc/13/a2.img
http://adchoice.feedsportal.com/r/24.../sc/13/ach.imghttp://pi.feedsportal.com/r/24739335.../sc/13/a2t.imghttp://pi2.feedsportal.com/r/2473933...sc/13/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...4Y:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...4Y:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/MPQxwT5hFaA